TMX Newsfile

IN THE PRESS

Press Releases

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz’s Team and an “Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence

January 12, 2026

·

1 min read

Press Releases

BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer

January 8, 2026

·

9 min read

Press Releases

MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million

January 8, 2026

·

7 min read

Press Releases

BioHarvest Sciences Issues Year End Shareholder Letter

January 7, 2026

·

8 min read

Press Releases

TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network

January 6, 2026

·

5 min read

Press Releases

Moss Genomics Reports Bitcoin Cash (BCH) Mining Activity

January 5, 2026

·

3 min read

Press Releases

PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring

January 5, 2026

·

10 min read

Press Releases

OS Therapies Provides First Half 2026 Corporate Outlook

January 5, 2026

·

8 min read

Press Releases

TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026

January 2, 2026

·

9 min read

Press Releases

PharmaTher CEO Publishes Letter to Shareholders

January 2, 2026

·

7 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750